|
|
Dr. John Burk - Presentations,
Publications, and Clinical Trials
|
Presentations:
1. "Auto-CPAP in the Treatment of Obstructive Sleep
Apnea," Mid West Association of Polysomnographic Technologists, Rosemont,
Illinois, November 10, 1995.
2.
"Auto-CPAP in the Treatment of CPAP-Using Obstructive Sleep Apnea
Patients," International Scientific Assembly of the American College of
Chest Physicians, 61st Annual Meeting, New York, New York, October 29-November
2, 1995.
3.
"Indications and Considerations for Auto-CPAP Therapy," Association
of Polysomnographic Technologists, Nashville, Tennessee, June 1995.
4.
"Auto-CPAP (APAP) in the Treatment of Obstructive Sleep Apnea,"
European Respiratory Society, Nice, France, October 1994.
5.
"Auto-CPAP in the Initial Treatment of Obstructive Sleep Apnea (OSA)
Patients," Association of Professional Sleep Societies, Seventh Annual
Meeting, Los Angeles, California, June 1993.
6.
"Auto-CPAP in the Initial Treatment of Obstructive Sleep Apnea (OSA)
Patients," Advances in Sleep Medicine, Winter Meeting, February 1993.
7.
"Auto-CPAP in the Treatment of Obstructive Sleep Apnea: A New
Approach," Association of Professional Sleep Societies, Phoenix, Arizona,
June 1992.
8.
"Auto-CPAP in the Treatment of Obstructive Sleep Apnea: A New
Approach," Advances in Sleep Medicine, Winter Meeting, February 1992.
9.
"Who Should Have Sleep Studies?" Texas Medical Association Annual
Meeting, May 1989.
10.
"Epidemiology of Nursery Exposure to Tuberculosis," American College
of Chest Physicians, November 1977.
11.
"Consecutive Cases of Fiberoptic Transbronchial Pulmonary Biopsy,"
KOPPA Conference, Hunt, Texas, August 1976; presented with R. L. Ragsdale and
J. Robertson.
12.
"Hypertension Control: Where Do We Stand Now in Alabama?" CIBA
Symposium, Birmingham, Alabama, November 1975.
Publications:
13. Burk, John R: Automatic CPAP: The Next Generation. RT
Magazine, June/July 1999, pages 37-42.
14.
Lucas EA, Behbehani K, Bradshaw CM, Burk JR, Knaur S, Wexler DM: Comparison of
Continuous Positive Airway Pressure (CPAP) to AutoCPAP* (APAP) in the Diagnosis
and Treatment of Obstructive Sleep Apnea. Sleep, Volume 21, Number 3,
Supplement, 1998, page 106.
15.
Yen FC, Behbehani K, Lucas EA, Burk JR, Axe JR: A Noninvasive Technique for
Detecting Obstructive and Central Sleep Apnea. IEEE Transactions on Biomedical
Engineering, Volume 44, Number 12, December 1997, pp 1262-1268.
16.
Behbehani KR, Becker PM, Burk JR, Jamieson AO, Jewell CE, Knaur SL, Lucas EA,
Shehadeh F and Smith ML: ABSTRACT: Hours of Use Is Increased and Mean
Therapeutic Pressure Is Reduced by Auto CPAP (APAP) Therapy in CPAP Treated
Obstructive Sleep Apnea Patients. Sleep Research, Volume 26, page 326, Chase
MH, Rosenthal LD, O'Connor C, eds. 1997.
17.
Smith ML, Becker PM, Behbehani K, Burk JR, Jamieson AO, Jewell CE, Knaur SL,
Lucas EA and Shehadeh F: ABSTRACT: Comparison of Auto CPAP (APAP) and Fixed
CPAP Therapy on Nocturnal Blood Pressure Changes in Patients with Obstructive
Sleep Apnea. Sleep Research, Volume 26, page 511, Chase MH, Rosenthal LD,
O'Connor C, eds. 1997.
18.
Behbehani KR, Lopez F, Yen F-C, Lucas EA, Burk JR, Axe JP, Kamangar F:
Pharyngeal Wall Vibration Detection Using an Artifical Neural Network. Medical
& Biological Engineering & Computing, Volume 35, May 1997, pp 193-198.
19.
Behbehani KR, Yen F-C, Burk JR, Lucas EA, Axe JR: Automatic Control of Airway
Pressure for Treatment of Obstructive Sleep Apnea. IEEE Transactions on
Biomedical Engineering, Volume 42, Number 10, October 1995, pp 1007-1016.
20.
Creticos P, Burk JR, Smith L, Comp R, Norman P, Findlay S: The Use of Twice
Daily Nedocromil Sodium in the Treatment of Asthma. Journal of Clinical
Immunology, April 1995.
21.
Burk JR: Community Ethics Conference Report. Tarrant County Physician, Volume
66, Number 4, April 1994, p 35.
22.
Burk JR: Camp El Tesoro de la Vida. Tarrant County Physician, Volume 62, Number
6, June 1990, p 33.
23.
Wooten V, Lucas EA, Burk JR: Positive Nasal Airway Pressure Eliminates Snoring
As Well As Obstructive Sleep Apnea. Pulmonary Disease Review, Volume 6, 1986,
pp 575-583.
24.
Burk JR, Viroslav J, Bynum LJ: Miliary Tuberculosis Diagnosed by Fiberoptic
Bronchoscopy and Transbronchial Biopsy. Tubercle, Volume 59, 1978, pp 107-109.
25.
Burk JR, Bahar D, Wolf FS, Greene J, Bailey WC: Nursery Exposure of 528
Newborns to Nurse with Tuberculosis. The Southern Medical Journal, Volume 71,
Number 1, January 1978, pp 7-10.
26.
Burk JR, Lertora JJL, Maetinex IM, Fisher JW: Renal Cell Carcinoma with
Erythrocytosis and Elevated Erythropoietic Stimulatory Activity. The Southern
Medical Journal, Volume 70, Number 8, August 1977.
27.
Burk JR: Hypertension Control: Where Do We Stand Now in Alabama? the Journal of
the Medical Association of the State of Alabama, Volume 45, Number 9, March
1976, pp 26-28.
28.
Burk JR, Snow R, Sellers C, Hicks A, Maetz M, Atkins R, Lindsey HS: St. Louis
Encephalitis in Jefferson County-1974: What Does the Future Hold? The Journal
of the Medical Association of the State of Alabama, Volume 44, Number 12, June
1975, pp 693-697.
29.
Burk JR, Lehman HF, Wolf FS: Inadequacy of Papanicolaou Smears in the Detection
of Endometrial Cancer. The New England Journal of Medicine, Volume 291, Number
4, July 25, 1974, pp 191, 192.
Clinical Trials:
"Auto-CPAP With and Without a Humidifier." Study
1CA5052, Respironics, Inc., April 1995 to December 1996, Principle
Investigator.
"A Multicenter Study for the Correlation Between the Findings of
Atypical/Malignant Cells in Sputum and Fluorescent Bronchoscopy Using the LIFE
Imaging System and White Light Bronchoscopy." Protocol LS01, Xillix
Technologies Corporation, June 1994 (ongoing at this time), Principal
Investigator.
"A Multicenter, Prospective Survey to Evaluate Purulent
Lower Respiratory Tract Exacerbations in the Outpatient Setting." Study
Z0556n, Genentech, Incorporated, July 1995, Co-Investigator.
"Real-Time Non-Invasive Method for Estimating Upper Airway
Impedance of Apnea Patient During Sleep." December 1994 to December 1996,
Principal Investigator.
"A Multinational, Multicenter, Double-blind, Placebo-Controlled Phase III
Study to Evaluate the Efficacy and Safety of Aerosolized Recombinant Human
DNase I in Hospitalized Patients with Chronic Obstructive Pulmonary Disease
Experiencing a Pulmonary Exacerbation." August 1994 to September 1995,
Principal Investigator.
"Enhanced CPAP Therapy for Obstructive Sleep Apnea."
Study 1 R15 HL46467-01A1, National Institutes of Health and the University of
Texas at Arlington, September 1992 to August 31, 1994, Co-Investigator. "A
Microprocessor-Controlled Continuous Positive Airway Pressure System for
Treating Obstructive Respiratory Impairments in Sleep." January 1992 to
September 1995, Co-Investigator.
"Prospective, Controlled, Third Party-Blind, Randomized Study Comparing
the Efficacy and Safety of IV/PO Ciprofloxacin (400/500 mg q.12h.) with
Parenteral IV or IM Ceftriaxone (1000 mg q.24h.) in the Treatment of Patients
with Pneumonia (Multi-Center)." Study D89-027, Miles, Inc., Pharmaceutical
Division, November 1990, Principal Investigator.
"Prospective, Controlled, Randomized Study Comparing the
Efficacy and Safety of Intravenous Ciprofloxacin with Standard Antibiotic
Therapy in the Treatment of Selected Tissue Infections (Multi-Center)."
Study D90-034, Miles, Inc., Pharmaceutical Division, November 1990,
Co-Investigator.
"The Effect of Zolpidem in Elderly Patients with Chronic Insomnia."
Study LSH-21, Lorex Pharmaceuticals, January 1990, Principal Investigator.
"Cefaclor A.F. vs. Cefaclor in Various Bacterial Infections." Study
B3M-M-AIKA, Eli Lilly & Company, January 1989, Co-Investigator.
"Development of a Microprocessor-Based Sleep Apnea Ventilator."
Project #1805, Texas Higher Education Coordination Board and the University of
Texas at Arlington, June 1, 1988 to August 31, 1991, Co-Investigator. "A
Comparison of the Efficacy and Tolerance of Ventolin in Solution for Inhalation
to Alupent Inhalant Solution to Placebo in Home Nebulization in Adults with
Chronic Obstructive Pulmonary Disease." Glaxo Pharmaceuticals, April 1988,
Principal Investigator.
"A Comparative Study of the Long Term Safety Profile of Estazolam,
Triazolam, and Placebo in Adults with Insomnia." Abbott Laboratories,
1987-1988, Co-Investigator.
"A Double-Blind Multicenter Group Comparative Study of the
Efficacy and Safety of Tilade b.i.d. (Nedocromil Sodium) vs. Placebo in the
Management of Adults with Reversible Airway Obstruction." Study 87-11A,
Fisons, November 1987, Principal Investigator.
"A Comparative Patient Preference Study of Two Actuators for Ventolin
Inhalers." Study SAL-508-3, Glaxo Pharmaceuticals, June 1987, Principal
Investigator.
"Compassionate Use of Ciprofloxacin in the Treatment of a Patient With an
Infection Refractory to Currently Marketed Antibiotics." Study U86-006-96,
Miles Laboratories, August 1986, Co-Investigator.
"A Comparative Study of the Side Effect Profile of Estazolam, Flurazepam,
Temazepam, Triazolam, and Placebo in Adult Patients Complaining of
Insomnia." Protocol M84-051, Abbott Laboratories, 1986, Co-investigator.
|
|
Back To Dr. John Burk C.V. |
Back To
Doctors | Back Home |
|
Material
Copyright © 2001 Texas Pulmonary Consultants
|
|